Qube Research & Technologies (QRT)’s Cardlytics CDLX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$88.7K	Buy	+19,765	New	+$148K	﹤0.01%	3033
2026 Q1	–	Sell	-19,176	Closed	-$221K	–	3580
2025 Q4	$221K	Buy	19,176 +16,924	+752%	+$261K	﹤0.01%	3034
2025 Q3	$54.7K	Buy	+2,252	New	+$37.5K	﹤0.01%	3170
2024 Q2	–	Sell	-1,216	Closed	-$176K	–	3879
2024 Q1	$176K	Sell	1,216 -700	-37%	-$59.1K	﹤0.01%	3080
2023 Q4	$176K	Buy	+1,916	New	+$195K	﹤0.01%	2849
2022 Q3	–	Sell	-2,424	Closed	-$541K	–	2543
2022 Q2	$541K	Buy	+2,424	New	+$812K	﹤0.01%	1377
2021 Q2	–	Sell	-654	Closed	-$718K	–	2310
2021 Q1	$718K	Buy	+654	New	+$864K	0.01%	985
2020 Q2	–	Sell	-636	Closed	-$222K	–	1730
2020 Q1	$222K	Buy	636 +193	+44%	+$137K	0.01%	833
2019 Q4	$279K	Buy	+443	New	+$217K	0.01%	1248

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.88B AUM 2.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return

WPM

Worldly Partners Management Needham, Massachusetts $122M AUM 11.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CDLX Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Cardlytics (CDLX) in Q2 2026: 19,765 shares worth $88.7K. The stake represents ﹤0.01% of the portfolio and ranks #3033 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in CDLX as recently as Q4 2025.

Qube Research & Technologies (QRT) first reported a position in CDLX in Q4 2019 and has held it in 9 quarters since. The position peaked at $718K in Q1 2021. 42 funds tracked by Wall St. Rank hold CDLX as of Q2 2026.

Qube Research & Technologies (QRT) held 19,765 shares of Cardlytics worth $88.7K as of Q2 2026.
Cardlytics was a new Qube Research & Technologies (QRT) position in Q2 2026.
Cardlytics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #3033 holding.
Qube Research & Technologies (QRT) first reported a position in Cardlytics in Q4 2019 and has held it in 9 quarters since.
Qube Research & Technologies (QRT)'s Cardlytics position peaked at $718K in Q1 2021.
42 funds tracked by Wall St. Rank held Cardlytics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.